KR20130041417A - Black ginseng drink for improving lipid metabolism and its manufacturing method - Google Patents
Black ginseng drink for improving lipid metabolism and its manufacturing method Download PDFInfo
- Publication number
- KR20130041417A KR20130041417A KR1020110105636A KR20110105636A KR20130041417A KR 20130041417 A KR20130041417 A KR 20130041417A KR 1020110105636 A KR1020110105636 A KR 1020110105636A KR 20110105636 A KR20110105636 A KR 20110105636A KR 20130041417 A KR20130041417 A KR 20130041417A
- Authority
- KR
- South Korea
- Prior art keywords
- black ginseng
- ginseng
- black
- weight
- manufacturing
- Prior art date
Links
- 241000208340 Araliaceae Species 0.000 title claims abstract description 40
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 40
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 40
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 40
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 13
- 230000037356 lipid metabolism Effects 0.000 title claims description 8
- 230000032683 aging Effects 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000012907 honey Nutrition 0.000 claims abstract description 6
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 5
- 238000005406 washing Methods 0.000 claims abstract description 4
- 235000020710 ginseng extract Nutrition 0.000 claims description 18
- 235000013361 beverage Nutrition 0.000 claims description 11
- 238000000034 method Methods 0.000 abstract description 4
- 239000004480 active ingredient Substances 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 150000002632 lipids Chemical class 0.000 description 7
- 235000005911 diet Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 235000009200 high fat diet Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 206010019851 Hepatotoxicity Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000004153 glucose metabolism Effects 0.000 description 2
- 230000007686 hepatotoxicity Effects 0.000 description 2
- 231100000304 hepatotoxicity Toxicity 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000005070 ripening Effects 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 210000000579 abdominal fat Anatomy 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/26—Homogenisation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
Description
본 발명은 지질대사 개선용 흑삼음료 및 그 제조방법에 관한 것이다.The present invention relates to a black ginseng drink for improving lipid metabolism and a method of manufacturing the same.
흑삼은 백삼, 홍삼에 없는 유효 사포닌이 다량으로 들어있으며, 특히 당뇨에 필요한 아드레날린과 인슐린 생성에 영향을 주는 작용을 하므로 당뇨병, 간기능 강화에 도움을 주고 각종 간질환을 회복시키며, 콜레스테롤의 대사를 조절하고 생성을 억제하는 작용을 한다.Black ginseng contains a large amount of effective saponins that are not found in white ginseng and red ginseng. In particular, black ginseng has effects on adrenaline and insulin production needed for diabetes, helping to strengthen diabetes, liver function, recovering various liver diseases, and metabolizing cholesterol. It acts to regulate and inhibit production.
그러나, 이러한 흑삼을 간편하게 음료로 복용할 수 있는 가공식품에 대한 연구는 이루어지지 않고 있다.However, research on processed foods that can easily take such a black ginseng has not been made.
본 발명은 흑삼을 간편하게 음료로 섭취하도록 하면서, 유효성분의 섭취를 극대화시킬수 있도록 하고, 지질대사 개선 효과를 갖는 음료 및 그 제조방법을 제공하는 데 목적이 있다.The present invention is intended to provide a beverage and a method for producing the same, while allowing black ginseng to be easily consumed as a beverage, maximizing the intake of the active ingredient, and improving the lipid metabolism.
상기한 목적을 달성하기 위한 본 발명의 특징은, 음료 총중량 기준으로 흑삼진액 10~20 중량%(고형분함량 5~30%), 꿀을 약 5-10중량%, 물 70~85중량%로 구성되는 것을 특징으로 하는 흑삼 음료에 있다.Characteristic of the present invention for achieving the above object, 10 to 20% by weight of black ternary juice (solid content 5 to 30%), about 5-10% by weight of honey, 70 to 85% by weight of water based on the total weight of the beverage Black ginseng drink is characterized in that.
그리고, 본 발명의 다른 특징은 인삼을 세척 후 60℃~80℃에서 20일간 숙성시켜 흑삼을 제조하는 과정과, 상기 흑삼을 믹서기로 균질화하여 진액을 얻는 과정, 상기 흑삼 진액10~20 중량%(고형분함량 5~30%), 꿀을 약 5-10중량%, 물 70~85중량를 혼합하여 음료를 제조하는 과정을 포함하는 지질대사 개선용 흑삼음료 제조방법에 있다.Further, another feature of the present invention is the process of preparing black ginseng by washing the ginseng and then aging at 60 ° C. to 80 ° C. for 20 days, and homogenizing the black ginseng with a blender to obtain a essence solution, 10 to 20% by weight of the black ginseng essence ( Solid content 5 ~ 30%), about 5-10% by weight of honey, 70 ~ 85% by weight of water to manufacture a beverage for improving lipid metabolism comprising the process of preparing a beverage.
상기한 본 발명에 의하면 기호성이 우수한 흑삼 음료를 제공할 수 있게 된다.According to the present invention described above it is possible to provide a black ginseng beverage excellent in palatability.
또한, 진액을 사용함으로서 유효성분의 섭취를 극대화시킬 수 있는 장점이 있으며, 숙성시킨 흑삼을 동물에 급여하여 혈중 포도당 억제효능과 중성지질 및 콜레스테롤 억제 효능을 확인함으로써 지질 및 당질대사 개선에 효과가 있는 음료를 ㅈ제공할 수 있게 된다.In addition, it has the advantage of maximizing the intake of the active ingredient by using the essence, and by feeding the aged black ginseng to the animal to check the blood glucose inhibitory effect, neutral lipid and cholesterol inhibitory effect, which is effective in improving lipid and glucose metabolism You will be able to serve drinks.
이하 본 발명의 실시예를 첨부된 도면을 참조하여 살펴본다.
Hereinafter, an embodiment of the present invention will be described with reference to the accompanying drawings.
1. 흑삼 제조1. Black Ginseng Manufacturing
흑삼은 인삼을 세척 후 60℃~80℃에서 20일간 숙성시켜 제조한다.Black ginseng is prepared by washing ginseng and aging for 20 days at 60 ℃ ~ 80 ℃.
이러한 흑삼을 제조하기 위한 숙성장치를 살펴보면, 자연 순환적인 공기 흐름을 통해 흑삼 숙성의 최적 조건이 균일하고 안정되게 유지 가능하도록 하는 것으로, 가열수단이 구비된 숙성로 내부에서 인삼이 인삼 교반부에 의하여 그 위치가 선회되고, 상기 숙성로 하부에는 공기를 토출하는 1개 이상의 토출관을 형성하고 상단에는 공기를 흡입하는 흡입관을 설치하여 로내 공기를 숙성로내에서 순환시키거나 로외 공기를 숙성로 내부로 주입함으로서, 자연 순환적인 공기 흐름을 통해 숙성로 내부가 균일한 온도 및 습도가 유지되도록 하여, 숙성시간이 단축되면서 고품질의 흑삼을 제공할 수 있도록 하였다.
Looking at the ripening device for producing such black ginseng, to ensure that the optimum conditions of black ginseng ripening through a natural circulating air flow can be maintained uniformly and stably, the ginseng inside the aging furnace equipped with a heating means by the ginseng stirring unit The position is rotated, and at least one discharge tube for discharging air is formed at the lower part of the aging furnace, and a suction tube for sucking air is installed at the upper end to circulate the air in the furnace in the aging furnace or the furnace outside the aging furnace. By injecting, the inside of the aging furnace through the natural circulating air flow to maintain a uniform temperature and humidity, shortening the aging time to provide a high quality black ginseng.
2. 흑삼 음료 제조2. Black Ginseng Beverage Manufacturing
① 숙성한 흑삼의 뇌두를 잘라낸다.① Cut off the head of aged black ginseng.
② 상기 숙성 흑삼에 중량비로 5.7배량의 물을 첨가하여 믹서기로 균질화하고, 섬유질만을 망을 이용하여 걸러내어 흑삼진액을 제조한다.② Add 5.7 times of water in weight ratio to the aged black ginseng, homogenize it with a blender, and filter out only fiber using a net to prepare black ssam extract.
상기에서 숙성한 흑삼은 마치 찐고구마와 유사한 질감이므로, 그대로 균질화시켜서 섬유질만을 걸러내는 공정만으로 음료제조가 가능하다.Black ginseng ripened in the above is a texture similar to steamed sweet potatoes, it is possible to manufacture a beverage only by homogenizing as it is filtering the fiber only.
③ 상기 흑삼 진액 15%(고형분함량 10%), 꿀 약 5-10중량%, 물 75~80중량를 혼합하여 음료를 제조한다.
③ The beverage is prepared by mixing the black ginseng extract 15% (solid content 10%), honey about 5-10% by weight, water 75-80%.
3. 흑삼의 생리활성 효능 검정3. Assay of physiological activity efficacy of black ginseng
고 지질식이에 의해서 당뇨 및 고지혈증이 유도되는 마우스에 흑삼 추출물을 보충급여하면서 사육한 마우스의 지질 및 당질 대사 개선 효능을 검토하였다. The effects of lipid and glucose metabolism improvement on mice bred with supplementation of black ginseng extract in mice induced with diabetes and hyperlipidemia by high lipid diet were examined.
하기에서 N은 일반식이, HF는 고지질식이, HF+G는 고지질식이에 수삼추출물투여군, HF+BG는 고지질식이에 흑삼추출물 식이군을 나타내며, 상기에서 흑삼추출물 및 수삼추출물은 흑삼 1 kg에 6-10배량의 물을 첨가하여 121℃에서 1시간 추출한 추출물(열수 추출물)을 동결건조시켜, 각각 사료에 5 % 배합하여 급여하였다.
In the following, N is a general diet, HF is a high-fat diet, HF + G is a high-fat diet, ginseng extract administration group, HF + BG is a high-fat diet black ginseng extract diet group, in the black ginseng extract and the fresh ginseng extract is black ginseng 1 Six to ten times the amount of water was added to the kg, and the extract (hot water extract) extracted at 121 ° C. for 1 hour was lyophilized, and was fed by mixing 5% with each feed.
(1) 흑삼 추출물 식이에 의한 체중변화 및 식이섭취율 및 지방조직의 변화(1) Changes in Body Weight, Dietary Intake and Adipose Tissue by Black Ginseng Extract Diet
흑삼 추출물을 보충급여하면서 사육한 동물의 체중 및 장기 중량 증가를 비교한 결과(표 1), 식이 섭취율에는 별반 차이가 없었음에도 불구하고 흑삼 추출물을 급여한 군(HF+BG)의 체중 감소 효과가 두드러짐을 알 수 있고, 특히 복부지방 조직의 감소효과가 뚜렷함을 알 수 있다.As a result of comparing the weight and organ weight gain of the animals reared with supplemented black ginseng extract (Table 1), the weight loss effect of the group fed the black ginseng extract (HF + BG) was not significantly different. It can be seen that the prominence, in particular the abdominal fat tissue reduction effect is clear.
(2) 혈장 중성지질의 농도 변화(2) changes in plasma triglyceride concentration
(3) 혈장 총 콜레스테롤 함량 변화(3) changes in plasma total cholesterol content
(4)혈장의 HDL-콜레스테롤 함량 변화(4) Change of HDL-cholesterol content in plasma
(5)혈장의 lipid profile을 분석한 결과(5) Analysis of lipid profile of plasma
또한 혈장의 lipid profile을 분석한 결과(표 5), 고 지질 식이에 의해서 유도되는 총 콜레스테롤 함량이 감소하는 효과가 있었으며, HDL-콜레스테롤 함량은 증가하고 있으며, 동맥경화지수는 감소하고 있는 등 지질대사 개선에 효과적임을 알 수 있었다. 이러한 효과는 수삼추출물에 비해서 흑삼추출물에서 더욱 효과적이었다. In addition, as a result of analyzing the lipid profile of plasma (Table 5), total cholesterol content induced by high lipid diet was decreased, HDL-cholesterol content was increased, and arteriosclerosis index was decreased. It was found to be effective for improvement. This effect was more effective in black ginseng extract than ginseng extract.
(6) 간독성 지표인 GOT, GPT 레벨(6) GOT and GPT levels as indicators of hepatotoxicity
간독성 지표인 GOT, GPT 레벨(표 6) 또한 흑삼추출물 보충급여의 경우, 감소하고 있었으며, 수삼추출물에 비해서 흑삼추출물에서 더욱 효과적이었다. GOT and GPT levels (Table 6), which are indicators of hepatotoxicity, were also decreased in the supplementation of black ginseng extract, and were more effective in the black ginseng extract than the fresh ginseng extract.
(7)적혈구의 항산화 효소활성을 검정한 결과(7) As a result of assaying antioxidant enzyme activity of red blood cells
적혈구의 항산화 효소활성을 검정한 결과(표 7), 대표적인 항산화 효소인 카탈라아제, 글루타치온퍼옥시다아제 등의 활성이 흑삼 추출물 급여에 의해서 활성화되고 있었으며, 이러한 효과 또한 수삼추출물에 비해서 흑삼추출물에서 더욱 효과적이었다. As a result of assaying the antioxidant enzyme activity of erythrocytes (Table 7), the activities of catalase and glutathion peroxidase, which are representative antioxidant enzymes, were activated by black ginseng extract, and this effect was more effective in black ginseng extract than ginseng extract.
Claims (2)
상기 흑삼을 믹서기로 균질화하여 진액을 얻는 과정,
상기 흑삼 진액10~20 중량%, 꿀을 약 5-10중량%, 물 70~85중량를 혼합하여 음료를 제조하는 과정을 포함하는 것을 특징으로 하는 지질대사 개선용 흑삼음료 제조방법After washing ginseng and aging for 20 days at 60 ℃ ~ 80 ℃ to produce black ginseng,
Homogenizing the black ginseng with a blender to obtain a essence,
The black ginseng juice manufacturing method for improving lipid metabolism, characterized in that it comprises a process for preparing a beverage by mixing 10 ~ 20% by weight of the black ginseng extract, about 5-10% by weight of honey, 70 ~ 85% by weight of water
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020110105636A KR101357112B1 (en) | 2011-10-17 | 2011-10-17 | Black ginseng drink for improving lipid metabolism and its manufacturing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020110105636A KR101357112B1 (en) | 2011-10-17 | 2011-10-17 | Black ginseng drink for improving lipid metabolism and its manufacturing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20130041417A true KR20130041417A (en) | 2013-04-25 |
| KR101357112B1 KR101357112B1 (en) | 2014-02-04 |
Family
ID=48440562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020110105636A KR101357112B1 (en) | 2011-10-17 | 2011-10-17 | Black ginseng drink for improving lipid metabolism and its manufacturing method |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR101357112B1 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102024272B1 (en) * | 2018-06-12 | 2019-09-24 | 조미리 | Manufacturing method for black ginseng drink and black ginseng drink manufactured by the same |
| CN110558464A (en) * | 2019-10-12 | 2019-12-13 | 吉林人参研究院（吉林省长白山天然药物研究院） | A liquid beverage prepared from sun-dried Ginseng radix and radix Ginseng Indici, and its preparation method |
| CN110558470A (en) * | 2019-10-12 | 2019-12-13 | 吉林人参研究院（吉林省长白山天然药物研究院） | A solid beverage prepared from sun-dried Ginseng radix and radix Ginseng Indici, and its preparation method |
| CN110637961A (en) * | 2019-10-12 | 2020-01-03 | 吉林人参研究院（吉林省长白山天然药物研究院） | A solid beverage prepared from black ginseng, and its preparation method |
| CN111149964A (en) * | 2020-02-19 | 2020-05-15 | 吉林人参研究院（吉林省长白山天然药物研究院） | A liquid beverage prepared from black ginseng and peptide, and its preparation method |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102340751B1 (en) | 2020-10-16 | 2021-12-21 | 정문성 | Method for manufacturing black ginseng drink using fermented black ginseng and black ginseng drink manufactured by the same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100472098B1 (en) * | 2002-11-15 | 2005-03-11 | 김항종 | Manufacturing method of health drink using black ginseng and black rice |
| KR20100088794A (en) * | 2009-02-02 | 2010-08-11 | 인제대학교 산학협력단 | Composition comprising the extract of pleurotus eryngii for treating and preventing diabetic complication and lipid metabolism disorder by type 2 diabetes |
-
2011
- 2011-10-17 KR KR1020110105636A patent/KR101357112B1/en not_active IP Right Cessation
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102024272B1 (en) * | 2018-06-12 | 2019-09-24 | 조미리 | Manufacturing method for black ginseng drink and black ginseng drink manufactured by the same |
| CN110558464A (en) * | 2019-10-12 | 2019-12-13 | 吉林人参研究院（吉林省长白山天然药物研究院） | A liquid beverage prepared from sun-dried Ginseng radix and radix Ginseng Indici, and its preparation method |
| CN110558470A (en) * | 2019-10-12 | 2019-12-13 | 吉林人参研究院（吉林省长白山天然药物研究院） | A solid beverage prepared from sun-dried Ginseng radix and radix Ginseng Indici, and its preparation method |
| CN110637961A (en) * | 2019-10-12 | 2020-01-03 | 吉林人参研究院（吉林省长白山天然药物研究院） | A solid beverage prepared from black ginseng, and its preparation method |
| CN111149964A (en) * | 2020-02-19 | 2020-05-15 | 吉林人参研究院（吉林省长白山天然药物研究院） | A liquid beverage prepared from black ginseng and peptide, and its preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| KR101357112B1 (en) | 2014-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101357112B1 (en) | Black ginseng drink for improving lipid metabolism and its manufacturing method | |
| CN103981050B (en) | A kind of preparation method of dried Fructus Vitis viniferae morat | |
| CN109042790A (en) | A kind of preparation method of xylitol mulberry leaf biscuit | |
| CN106858139A (en) | A kind of ganoderma lucidum method for producing egg | |
| CN107373177A (en) | A kind of young pigeon feed | |
| CN104738311B (en) | A kind of fish slurry fermented bean dregs and its production method and application | |
| CN106722961A (en) | The Fructus Chaenomelis ferment processing method and formula of antifatigue beauty treatment of calming the nerves | |
| CN103783616B (en) | A kind of zymolysis squash beverage and preparation method thereof | |
| CN104970328A (en) | Rosa roxbunghii fermented dried fruit | |
| KR101165276B1 (en) | A manufacturing method of rice wine made from sweet potato and a rice wine made by that manufacturing method | |
| CN103340426A (en) | Old goose pickled production method for inhibiting lipid oxidation | |
| CN106722473A (en) | A kind of Argentinian cream squash health food and preparation method thereof | |
| CN102302112A (en) | Honey fruit paste and preparation method thereof | |
| CN106036447A (en) | Health-care steamed bun with camellia sinensis flower and mushroom and preparation method thereof | |
| CN106261595A (en) | A kind of lentinus edodes health care steamed bread rich in dietary fiber and preparation method thereof | |
| CN105379842A (en) | Composite yoghourt and preparation method thereof | |
| CN105360915A (en) | Low-protein steamed sorghum bread applicable to diabetic nephropathy patient and making method thereof | |
| KR102048590B1 (en) | Fabricating method of supplementary feed for black goat comprising tangle and producing method of black goat meat thereform | |
| CN104026464A (en) | Preparation method and product of andrias davidianus nutritional health-care steamed bread | |
| CN105146318B (en) | A kind of method preparing leaven | |
| CN106720111A (en) | A kind of celery biscuit and preparation method thereof | |
| CN107319448A (en) | One kind fermentation cherry jam | |
| CN105360933A (en) | Lung-moistening cough-relieving noodles and preparation method thereof | |
| CN106234985A (en) | A kind of high protein lentinus edodes health care steamed bread and preparation method thereof | |
| CN1049089A (en) | Prevent and treat hypoferric anemia series food manufacture method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| AMND | Amendment | ||
| E601 | Decision to refuse application | ||
| AMND | Amendment | ||
| X701 | Decision to grant (after re-examination) | ||
| GRNT | Written decision to grant | ||
| LAPS | Lapse due to unpaid annual fee |